Regeneron Pharmaceuticals (REGN) Return on Capital Employed (2010 - 2026)

Regeneron Pharmaceuticals' (REGN) quarterly Return on Capital Employed came in at 10.19% in Q1 2026, down 105.0% year-on-year from 203.85% in Q1 2025, and up 2.54% quarter-over-quarter from 9.94% in Q4 2025.

Regeneron Pharmaceuticals (REGN) Return on Capital Employed (2010 - 2026) Analysis & Trends

Regeneron Pharmaceuticals' Return on Capital Employed history runs 17 years deep, the most recent figure standing at 10.19% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed fell 105.0% year-over-year to 10.19% in Q1 2026; TTM through Mar 2026 was 10.19%, a 105.0% decrease from a year earlier, with the FY2025 full-year figure at 10.28%, down 239.0% from the prior year.
  • Return on Capital Employed grew to 10.19% in Q1 2026 per REGN's latest filing, from 9.94% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 39.73% in Q1 2022 and bottomed at 9.94% in Q4 2025.
  • The 5-year median for Return on Capital Employed is 12.78% (2024), against an average of 16.26%.
  • Biggest YoY gain for Return on Capital Employed was 1174 bps in 2022; the steepest drop was 2466 bps in 2022.
  • Year by year, Return on Capital Employed stood at 18.73% in 2022, then retreated by 26 bps to 13.86% in 2023, then dropped by 14 bps to 11.86% in 2024, then dropped by 16 bps to 9.94% in 2025, then advanced by 3 bps to 10.19% in 2026.
  • Per Business Quant, the three latest REGN Return on Capital Employed figures stand at 10.19% (Q1 2026), 9.94% (Q4 2025), and 10.61% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -31.80%
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -107.40%
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 10.46%
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 21.10%
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 10.19%
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -68.84%
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 20.34%

Historic Data

Download Data
DateValue
Mar 31, 2026 10.19%
Dec 31, 2025 9.94%
Sep 30, 2025 10.61%
Jun 30, 2025 11.23%
Mar 31, 2025 11.24%
Dec 31, 2024 11.86%
Sep 30, 2024 12.00%
Jun 30, 2024 12.31%
Mar 31, 2024 12.78%
Dec 31, 2023 13.86%
Sep 30, 2023 15.18%
Jun 30, 2023 15.90%
Mar 31, 2023 16.68%
Dec 31, 2022 18.73%
Sep 30, 2022 25.37%
Jun 30, 2022 28.87%
Mar 31, 2022 39.73%
Dec 31, 2021 43.39%
Sep 30, 2021 39.62%
Jun 30, 2021 42.02%